Signal transducer and activator of transcription-3 (STAT-3) is constitutively activated in ovarian and
endometrial cancers and is implicated in uncontrolled cell growth. Thus, its disruption could be an effective approach to control
tumorigenesis.
Curcumin is a dihydroxyphenolic compound, with proven anti-
cancer efficacy in various
cancer models. We examined the anti-
tumor mechanism of
curcumin on STAT-3 and on the negative regulators of STAT-3, including
suppressors of cytokine signaling proteins (SOCS-1 and SOCS-3),
protein inhibitors of activated STAT (PIAS-1 and PIAS-3), and SH2 domain-containing
phosphatases (SHP-1 and SHP-2) in ovarian and
endometrial cancer cell lines. Treatment of
cancer cells with
curcumin induced a dose- and time-dependent decrease of constitutive
IL-6 expression and of constitutive and IL-6-induced STAT-3 phosphorylation, which is associated with decreased cell viability and increased cleavage of
caspase-3. The inhibition of STAT-3 activation by
curcumin was reversible, and phosphorylated STAT-3 levels returned to control levels 24 h after
curcumin removal. Compared to normal cells baseline expression of SOCS-3 was high in
cancer cells and a marked decrease in SOCS-3 expression was seen following
curcumin treatment. Overexpression of SOCS-3 in
curcumin-treated cells increased expression of phosphorylated STAT-3 and resulted in increased cell viability. Normal ovarian and endometrial cells exhibited high expression of PIAS-3
protein, whereas in
cancer cells the expression was greatly reduced.
Curcumin increased PIAS-3 expression in
cancer cells. Of significance,
siRNA-mediated knockdown of PIAS-3 overcomes the inhibitory effect of
curcumin on STAT-3 phosphorylation and cell viability. In conclusion,
curcumin suppresses JAK-STAT signaling via activation of PIAS-3, thus attenuating STAT-3 phosphorylation and
tumor cell growth.